Detalles de la búsqueda
1.
Outcomes of younger patients with mantle-cell lymphoma experiencing late relapse (>24 months): the LATE-POD study.
Blood
; 2024 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38754055
2.
Outcome after chimeric antigen receptor (CAR) T-cell therapy failure in large B-cell lymphomas.
Br J Haematol
; 204(1): 151-159, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37690811
3.
Biological features and outcome of diffuse large B-cell lymphoma associated with hepatitis C virus in elderly patients: Results of the prospective 'Elderly Project' by the Fondazione Italiana Linfomi.
Br J Haematol
; 201(4): 653-662, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36733229
4.
Management of patients with lymphoma and COVID-19: Narrative review and evidence-based practical recommendations.
Hematol Oncol
; 41(1): 3-15, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36251481
5.
Impact of anti-SARS-CoV-2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study.
Hematol Oncol
; 41(3): 343-353, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36521843
6.
Circulating cell-free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre-analytical biases.
Hematol Oncol
; 41(1): 50-60, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36251440
7.
High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy.
Ann Hematol
; 102(12): 3457-3463, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37650886
8.
Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas.
Radiol Med
; 128(5): 556-564, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37145214
9.
Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial.
Br J Haematol
; 196(5): 1184-1193, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34951009
10.
Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics.
Br J Haematol
; 198(1): 82-92, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35468225
11.
Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma: Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study).
Hematol Oncol
; 40(4): 609-616, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35612350
12.
Semen quality in non-Hodgkin lymphoma survivors: a monocentric retrospective study.
Hum Reprod
; 36(1): 16-25, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33257989
13.
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
Lancet
; 394(10216): 2271-2281, 2019 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31868632
14.
Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma.
Blood
; 132(2): 179-186, 2018 07 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29720487
15.
Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study.
Haematologica
; 105(9): 2298-2307, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33054054
16.
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study.
Haematologica
; 105(6): 1604-1612, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31537689
17.
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation.
Hematol Oncol
; 38(3): 257-265, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32356913
18.
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma.
Hematol Oncol
; 38(5): 698-704, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32816326
19.
Preliminary results of a counselling programme for fertility preservation in female cancer patients: The experience of the GEMME DORMIENTI network.
Eur J Cancer Care (Engl)
; 29(1): e13174, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31571303
20.
Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas.
Oncologist
; 24(8): e720-e729, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30552159